Variantyx is a CLIA/CAP laboratory providing Genomic Unity, a whole genome sequencing (WGS)-based testing program for diagnosis of rare inherited disorders. Its single method approach to comprehensive genetic testing identifies multiple variant types within a single patient sample to provide a unified clinical report.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/15/21 | $20,000,000 | Series C |
20/20 HealthCare Partners GHS Fund  IBM Ventures New Era Capital Partners Pitango Venture Capital Zander Lurie | undisclosed |
| 02/14/22 | $20,000,000 | Series C |
20/20 HealthCare Partners GHS Fund IBM Ventures New Era Capital Partners Pitango Venture Capital Quark Venture Zafrira Avnur | undisclosed |
| 10/18/23 | undisclosed |
20/20 HealthCare Partners New Era Capital Partners Peregrine Ventures Pitango HealthTech Robert Bosch Venture Capital | undisclosed |
